I’m sharing below an announcement for our next NCI Technology Webinar, on Jan. 31st from 11am-12pm. This webinar will feature a potential novel treatment for Retinitis Pigmentosa (RP). Dr. Becerra and her team at the National Eye Institute (NEI) developed a novel therapeutic pigment epithelium-derived factor (PEDF) peptide that exhibits a highly potent effect on photoreceptor protection in in vivo mouse models. Over 100,000 people in the U.S. and 1.5 million people worldwide suffer from RP, which leads to progressive photoreceptor cell degeneration and ultimately vision loss. This new therapeutic PEDF peptide has the potential to be a treatment option for the worldwide RP patient population and may also protect retinal cells from damage associated with glaucoma and age-related macular degeneration (AMD). The NEI is looking for a commercialization partner for this technology.
Register for a January 31st NIH Opportunity Webinar: "A Modified Pigment Epithelium-Derived Factor (PEDF) for Treatment of Age-related Eye Diseases" | |||
작성자 | 글로벌팀 | 소속부서 | 글로벌 |
---|---|---|---|
등록일 | 2024/01/22 | ||
모집일시 | 행사일시 | ||
링크(첨부파일 등) | |||
|
|||
이전글 | [한국환경연구원] 국립DMZ생물자원관 생물자원 산업화지원 수요 설문조사 | ||
다음글 | [고려대학교 보건대학원] 최고위과정 미래의료리더십포럼 모집 안내 |